🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

3 Days to Go! This EBAC-accredited #HFA2025 session dives into the unmet needs for interventions in heart failure and presents the latest clinical outcomes and treatment strategies for atrial shunt therapies. Gain expert insights on patient selection and right heart function.

Hypertension isn’t just a risk factor—it’s a gateway to HFpEF. Bridging clinical insights with pathophysiology is key to driving early intervention. On #WorldHypertensionDay, dive into clinical insights from #eSPACECRM2025 on how hypertension could worsen HFpEF. Watch now:

1 DAY TO GO! Join us tomorrow World experts are ready to explore how MRAs & nsMRAs are advancing care in heart, kidney & metabolic health. Be there for the latest insights on HFrEF, HFpEF & cardio-kidney-metabolic syndrome. Are you ready? tinyurl.com/2sse9jz6 #Cardiology,

1 Day to Go! Are you joining us at our session that will present the latest FAIR-HF2 trial data, IV iron dosing strategies, and guideline-based approaches for treating iron deficiency in heart failure? Do not miss this tomorrow at #HFA2025 - tinyurl.com/24nextsv

1 Day to go! Don’t miss this EBAC-accredited #HFA2025 session on interventional therapies in heart failure, featuring the latest clinical outcomes and treatment strategies for atrial shunt therapies. Get ready for expert insights that support evidence-based decision-making.

LIVE NOW at #HFA2025! Experts are sharing key data from FAIR-HF2 and discussing how IV iron therapy is reshaping clinical management of iron deficiency in heart failure. Focused on practical tools for reducing hospitalizations & improving patient outcomes Join us now!

Live symposium updates from #HFA2025 in Belgrade! Prof. Dr. Dr. Mahir Karakas, MBA presents FAIR-HF2 data on iron deficiency definitions and IV iron dosing strategies, followed by Prof. Stefan Anker discussing the accumulated evidence supporting IV iron in heart failure. Full

It’s a wrap! Clinical evidence, intravenous iron strategies, and case-focused insights were explored at our CME-accredited educational session at #HFA2025. A full room of attendees engaged with FAIR-HF2 data, guideline-based recommendations, and practical strategies for

LIVE NOW at #HFA2025! Join the EBAC-accredited session on mitral, tricuspid & atrial shunt therapies in heart failure. Discover the latest clinical outcomes, intervention strategies & insights in HFpEF. #HeartFailure #AtrialShunts #Mitral #Tricuspid #Transcatheter #CME #EBAC

Live symposium updates from #HFA2025 in Belgrade! Session now underway with opening remarks by Prof. Marat Fudim, MD MHS , followed by Prof. Felix Mahfoud presenting clinical outcomes and treatment strategies for atrial shunt therapies. A full room of attendees is engaged with the

It’s a wrap! A full room of attendees joined our CME-accredited session at #HFA2025 on mitral, tricuspid, and atrial shunt therapies in heart failure. Session highlights included unmet needs for interventions, evidence-based treatment strategies, and clinical data supporting

WE ARE LIVE NOW! Join the world’s leading experts as they explore the role of MRAs & nsMRAs in treating heart, kidney & metabolic risks. Don't miss out on these game-changing insights in HFrEF, HFpEF & cardio-kidney-metabolic syndrome. Join us now! #Cardiology #Diabetology

Live symposium updates from #HFA2025 in Belgrade! Discussion now underway on mineralocorticoid receptor antagonism across the cardio-kidney-metabolic spectrum, with opening insights from Prof. Maja Cikes and Prof. BiykemBozkurt Prof. Javed Butler and Prof. John McMurray are now

It’s a wrap! Our CME-accredited session at #HFA2025 on mineralocorticoid receptor antagonism in cardio-kidney-metabolic syndrome delivered focused clinical updates to a full room of attendees. Key topics included the role of MRAs in HFrEF, emerging evidence for non-steroidal

Countdown to 26 May! The iCARDIO Public Review on CVD in Obesity is open—your input can help strengthen global guidelines for better care & outcomes. Submit feedback now: icardioalliance.org #CVD #Obesity #PublicReview #HeartHealth #Cardiology

Missed #eSPACECRM2025 live? Explore the key takeaways via sessions on demand. Access replays, learn from global experts & implement optimal therapy in your practice. TMA doesn’t just follow the science, we help define the ecosystem where multi-organ innovation becomes clinical

Deadline Extended! The iCARDIO Public Review on CVD in Obesity Guidelines is open until 2 June. Don’t miss this opportunity to shape guidelines that aim to make a worldwide impact. Submit feedback: icardioalliance.org #CVD #Obesity #Cardiology #PublicReview

How do we move beyond BMI in understanding obesity? During module 1 of our online educational program, Dr. Holleboom & Dr. Sattar explore the pathophysiology of obesity, and will provide a comprehensive overview of its far-reaching health consequences and the need for a

Obesity is a complex biological disease - TMA’s translational model works to bridge that complexity with clinical education and collaborative practice. Sessions on demand from #eSPACECRM2025 available now. Watch here: espace-crm.org #ObesityCare #PatientCommunication

How do we move beyond BMI in understanding obesity? During module 1 of our online educational program, Dr. Holleboom & Dr. Sattar explore the pathophysiology of obesity, and will provide a comprehensive overview of its far-reaching health consequences and the need for a